Evaluating the Pharmacokinetic Interactions and Safety Between AD-2111 and AD-2112
Clinical trial NCT04375865 · COMPLETED
Trial details
- NCT number
- NCT04375865
- Sponsor
- Addpharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-30
- Primary completion
- 2020-07-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.